TYMP and breast carcinoma: To determine if targeting TP may also contribute to the reduced viability of breast cancer cells, TP engagement by CETSA was assessed MDA-MB-468 cell lysates, but no stabilization of TP was detected by any of the compounds, including Pyr (Figures S9 and S10).